Complications Associated With Central Venous Access in the NSICU: PICC vs CVC

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

152 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-13

Study Completion Date

2016-12-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to determine whether Peripherally Inserted Central Catheter or Centrally Inserted Venous Catheters have lower complication rates in the Neuroscience Intensive Care Unit. After admission to the Neuroscience ICU and if they require central access, patients will be randomized to receive a PICC or CVC and complications (such as pneumothorax, deep venous thrombosis, infection, etc.) will be tracked and compared between the two interventions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care

NCT01495429

Venous Thrombosis

COMPLETED PHASE3

Venous Site for Central Catheterization

NCT01479153

Critical Care Catheterization ICU

COMPLETED NA

Near-Infrared Light Devices Versus Landmark Approach for Peripheral Venous Access in Intensive Care Unit

NCT06234293

Upper Limb Edema Critical Illness

COMPLETED NA

Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurosurgical Intensive Care Unit

NCT03908866

Thromboses, Venous Infection Economic Problems

UNKNOWN NA

Comparison of Central and Peripheral Venous Catheters

NCT00122707

Respiratory Insufficiency Shock Coma

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

PICC Central Venous Catheter Central Line Neuro ICU Neuroscience ICU CVC

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PICC

Patients randomly assigned to receive a peripherally inserted central catheter and they will be monitored for either having a complication or no complication.

Group Type ACTIVE_COMPARATOR

peripherally inserted central catheter

Intervention Type DEVICE

Any complication associated with central access

CVC

Patients randomly assigned to receive a centrally inserted central catheter and they will be monitored for either having a complication or no complication.

Group Type ACTIVE_COMPARATOR

centrally inserted central catheter

Intervention Type DEVICE

Central access not associated with any complication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

peripherally inserted central catheter

Any complication associated with central access

Intervention Type DEVICE

centrally inserted central catheter

Central access not associated with any complication

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Adult patients admitted to the NSICU, who require central access for the treatment of their illness.

Exclusion Criteria

1. Current or recent (within 1 month) diagnosis of bacteremia
2. Current or recent (within 1 year with confirmed resolution by imaging) deep venous thrombosis
3. Existing central access
4. Non-English speaking
5. Requirement for emergent central access and unable to obtain consent in an emergency setting

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No